News
Larger absolute rivaroxaban benefit in diabetes: COMPASS
March 29, 2020
The new vascular low dose of rivaroxaban has had a slow start, but these results may stimulate use in patients with diabetes and stable disease.
![1]()
News
Wuhan data link COVID-19 with myocardial damage
March 27, 2020
Findings from 603 COVID-19 patients at two Wuhan hospitals showed a high incidence of myocardial damage that predisposes to higher mortality.
News
Cardiac symptoms can be first sign of COVID-19
March 26, 2020
Among those affected, acute myocardial injury is either apparent at presentation or develops after hospitalization.
![1]()
News
COVID-19 shifts telehealth to the center of cardiology
March 25, 2020
A series of recent mandates aimed at addressing barriers to telehealth ‘have come in a time of desperation,’ one New York–based cardiologist says.
![1]()
News
Dramatic rise in hypertension-related deaths in the United States
March 20, 2020
The ‘alarming’ increase in hypertension-related deaths between 2007 and 2017, was particularly prominent in the rural South.
![1]()
News
AFib-related cardiovascular deaths on the rise
March 19, 2020
PHOENIX, ARIZ. – A more pronounced increase in mortality rate was observed among black and white men.
![1]()
News
COVID-19 will test medical supply stocks
March 19, 2020
“In the matter of a week or two...I think we’ll get a feel for whether or not we really have enough of the supplies that it takes,” said Dr. Anthony Fauci.
News
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugs
March 18, 2020
Experts give ACE inhibitors and ARBs, cornerstones of cardiology therapy, a thumbs up despite a hypothetical adverse COVID-19 effect.
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
March 18, 2020
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2 inhibitors at a higher risk of ketoacidosis.
![1]()
News
PARAGON-HF: Optimal systolic pressure in HFpEF is 120-129 mm Hg
March 18, 2020
In largest-ever HFpEF trial, SBP of 120-129 mm Hg was associated with lowest cardiovascular risk.
